Cameroon
Central and West African state; one of eight countries selected for the ARILAC AMR laboratory programme.
Last refreshed: 7 May 2026 · Appears in 1 active topic
What does Cameroon's role in ARILAC mean for AMR surveillance across Central Africa?
Timeline for Cameroon
Mentioned in: Africa CDC and EU launch ARILAC for AMR
Pandemics and Biosecurity- What is the ARILAC programme and why is Cameroon involved?
- ARILAC is a four-year Africa CDC and EU initiative launched on 6 May 2026 to build antimicrobial resistance laboratory capacity across eight African Union states, including Cameroon.Source: Africa CDC
- How bad is AMR in Cameroon?
- Across 14 African countries assessed, only 1.3% of medical laboratories conduct routine AMR testing. Cameroon's selection for ARILAC reflects a recognised gap in its diagnostic infrastructure.Source: Africa CDC / ASLM
- What disease outbreaks has Cameroon faced recently?
- Cameroon has experienced recurring cholera outbreaks along the Lake Chad basin border zone, alongside broader public health strain from the anglophone conflict displacing hundreds of thousands.
Background
Cameroon sits at the junction of West and Central Africa, bordering Nigeria, Chad, the Central African Republic, the Republic of Congo, Gabon, and Equatorial Guinea. Its population of roughly 28 million (2024 estimate) is one of the continent's most linguistically diverse, with more than 280 languages alongside the two official ones, French and English. Yaoundé is the political capital; Douala is the commercial hub and the country's largest port. The country has a mixed economy anchored in oil exports, agriculture (cocoa, coffee, cotton), and timber, though growth has been uneven across its ten regions. Cameroon has been governed under President Paul Biya since 1982, making his tenure one of the longest of any sitting head of state. Ongoing anglophone separatist conflict in the North-West and South-West regions has displaced hundreds of thousands since 2016, straining public health infrastructure in those areas.
Cameroon is one of eight African Union member states selected for the ARILAC (Advancing Regional Integrated Laboratory Capacity for AMR Control) programme, launched in Addis Ababa on 6 May 2026 by Africa CDC, ASLM, and the European Union . The four-year programme targets antimicrobial resistance surveillance capacity on a One Health basis. Cameroon's selection reflects both its geographic position as a Central and West African corridor and persistent gaps in its laboratory infrastructure; the country has recorded cholera outbreaks along its Lake Chad border zone and has historically lacked the diagnostic throughput for systematic AMR monitoring.
